Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

• Main Authors: Darbà J (Author), Ramírez G (Author), García-Rivero JL (Author), Mayoralas S (Author), Pascual JF (Author), Vargas D (Author), Bijedic A (Author)
• Format: Book
• Published: Dove Medical Press, 2017-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Josep Darbà,1 Gabriela Ramírez,2 Juan L García-Rivero,3 Sagrario Mayoralas,4 José Francisco Pascual,5 Diego Vargas,6 Adi Bijedic7 1Department of Economics, Universitat de Barcelona, 2BCN Health Economics & Outcomes Research S.L., Barcelona, 3Hospital Laredo, Cantabria, 4Hospital Ramón y Cajal, M...